GC
CORT icon

Globeflex Capital’s Corcept Therapeutics CORT Stock Holding History

Globeflex Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-64,539
Closed -$1.12M – 484
2020
Q3 		$1.12M Sell
64,539
-4,228
-6% -$67.4K 0.3% 102
2020
Q2 		$1.16M Buy
+68,767
New +$966K 0.29% 105
2019
Q2 		– Sell
-10,000
Closed -$117K – 515
2019
Q1 		$117K Sell
10,000
-219
-2% -$2.72K 0.02% 399
2018
Q4 		$137K Sell
10,219
-20,100
-66% -$266K 0.03% 388
2018
Q3 		$425K Sell
30,319
-800
-3% -$11.2K 0.08% 327
2018
Q2 		$489K Sell
31,119
-93,337
-75% -$1.62M 0.1% 305
2018
Q1 		$2.05M Sell
124,456
-30,300
-20% -$561K 0.43% 51
2017
Q4 		$2.79M Sell
154,756
-97,782
-39% -$1.77M 0.78% 8
2017
Q3 		$4.87M Sell
252,538
-8,700
-3% -$130K 1.39% 4
2017
Q2 		$3.08M Sell
261,238
-6,463
-2% -$70.3K 0.76% 13
2017
Q1 		$2.93M Buy
267,701
+23,518
+10% +$207K 0.7% 12
2016
Q4 		$1.77M Hold
244,183
– – 0.44% 38
2016
Q3 		$1.59M Sell
244,183
-300
-0.1% -$1.75K 0.4% 64
2016
Q2 		$1.33M Hold
244,483
– – 0.37% 85
2016
Q1 		$1.14M Buy
244,483
+182
+0.1% +$709 0.31% 108
2015
Q4 		$1.22M Buy
244,301
+151,869
+164% +$685K 0.32% 99
2015
Q3 		$348K Buy
+92,432
New +$469K 0.07% 320

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Globeflex Capital's CORT Position: Q4 2020 in Review

Globeflex Capital sold out of Corcept Therapeutics (CORT) in Q4 2020, closing a stake of 64,539 shares — an estimated $1.12M sold.

Globeflex Capital first reported a position in CORT in Q3 2015 and held it in 17 quarters. The position peaked at $4.87M in Q3 2017. 226 funds tracked by Wall St. Rank hold CORT as of Q4 2020.

  • Globeflex Capital reported no remaining Corcept Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Globeflex Capital sold 64,539 Corcept Therapeutics shares in Q4 2020, an estimated $1.12M.
  • Globeflex Capital first reported a position in Corcept Therapeutics in Q3 2015 and held it in 17 quarters.
  • Globeflex Capital's Corcept Therapeutics position peaked at $4.87M in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2020.

Based on Globeflex Capital's 13F filing for Q4 2020, filed 11 Feb 2021.